The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Across 10 cohorts and 29 lifestyle and environmental signatures, comparing tumor DNA methylation in early-onset (<50) vs late-onset (≥70) colorectal cancer, one signal stood out: the herbicide picloram. Early onset tumors showed ~3 fold higher odds of carrying the picloram methylation signature in the discovery cohort, and 1.77-fold across all 10 pooled cohorts (114 early onset vs 372 late onset).
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Across 94 US counties over 21 years (1992 to 2012), picloram-use intensity correlated with increase in EOCRC incidence, the most robust signal among 62 pesticides tested.
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.